Indeed, SMO, GLI1, PTCH1, CD133 and aldehyde dehydrogenase (ALDH)-expressing GSCs are upregulated post-radiation in GBM neurospheres, which further supports the concept that standard therapies are not able to abolish GSCs [115]. The gene discussed is SMO; the disease is glioblastoma.